PA, plasminogen activator
Interaction between plasminogen activator inhibitor type 1 (PAI 1) bound to fibrin and either tissue type plasminogen activator (t PA) or urokinase type plasminogen activator (u PA) Binding of t PA/PAI 1 complexes to fibrin mediated by both the finger and the kringle 2 domain of t PA
... urokinase-type plasminogen activator ...by plasminogen activator inhibitor type 1 (PAI-1) that is either present in plasma or bound to fibrin, present in a ...activate plasminogen. Upon ...
10
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
... Figure 1 Intrapleural administration of t-PA and DNase increases the volume of output pleural fluid (PF). (A) Daily output of PF volume in mL for each randomisation arm of the MIST2 study: t-PA and DNase, ...
5
Two receptor systems are involved in the plasma clearance of tissue type plasminogen activator (t PA) in vivo
... circulation by the liver. Two distinct clearance mechanisms, which are mediated by the low density lipoprotein receptor-related protein (LRP) on liver parenchymal cells and by the mannose receptor on liver endothelial ...
6
Beta-amyloidolysis and glutathione in Alzheimer's disease
... macological effect of administration of BSO or diethyl maleate in rabbits is a significant decrease in GSH levels, accompanied by the inhibition of fibrinolytic activity important for the fibrin plate. This inhibition of ...
8
Association of dietary soy with expression of various pro-inflammatory genes in porcine phagocytes
... urokinase-plasminogen activator (u-PA), u-PA receptor (u- PAR), plasminogen activator inhibitor type 1 and 2 (PAI-1, PAI-2), intercellular adhesion molecule 1 (ICAM-1), ...
8
Sonothromblysis in Combination with Thrombolytic Drugs in a Rabbit Model Using MRI Guidance
... Tissue-Type Plasminogen Activator (rt- PA)) is a Phase II randomized multi-center international clinical trial [16]; b) The EKOS clinical trial [17] which involves the insertion of a catheter is now ...
5
Structural and kinetic comparison of recombinant human single and two chain tissue plasminogen activator
... monomer to eosin-labeled tct-PA, no effect on eosin fluorescence was noted. Eosin-labeled tct-PA had 16% less eosin fluorescence than did sct-PA and on addition of soluble fibrin monomer to ...
8
Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty
... The onset of DVT in patients after THA may expand or enlarge, and subsequently lead to pulmonary thrombo- embolism, a critical postoperative complication related to significant mortality [15]. Therefore, early diagnosis ...
5
Behçet’s disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity
... minogen activator (t-PA) (TriniLIZE tPA antigen ELISA kit) and plasminogen activator inhibitor type 1 (PAI-1) (TriniLIZE PAI-1 antigen ELISA kit); all kits were ac- quired from Trinity ...
9
Characterization of the intrinsic fibrinolytic properties of pro urokinase through a study of plasmin resistant mutant forms produced by site specific mutagenesis of lysine(158)
... amidolytic and plasminogen-activating activities of the mutants averaged 0.14 and 0.12% that of TC-UK, respectively. The fibrin plate activities were 2,400 IU/ml and 700 IU/mg for the Met158 and Val158 mutants or ...
8
Influence of the fast acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue type plasminogen activator in rabbits Interference of tissue derived components
... of plasminogen activator (PA-inhibitor) on thrombolysis was investigated in rabbits with a jugular vein ...tissue-type plasminogen activator (t-PA) produced similar degrees of ...
8
Preventing graft restenosis after coronary artery bypass grafting with tissue-type plasminogen activator
... t-PA is currently considered one of the most effec- tive drugs for preventing and treating thrombotic dis- eases and is commonly used in thrombolytic therapy for acute myocardial infarction [21, 22]. A recent ...
5
Key words
... of plasminogen to plasmin [2, ...the plasminogen-to-plasmin conversion ...minogen activator (pro-u-PA, single chain uroki- nase plasminogen activator: scu-PA) which is ...
8
Acceleration of the thrombin inactivation of single chain urokinase type plasminogen activator (pro urokinase) by thrombomodulin
... thrombomodulin between the inactivation rates of high molecular weight scu-PA, and a low molecular weight scu-PA which lacked the growth factor and kringle domains. Enzyme kinetic experiments with varying ...
6
Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase
... plasmatic plasminogen activators (PA) can be demonstrated after sodium dodecyl sulfate polyacrylamide gel electrophoresis of plasma freshly collected from resting volunteers, followed by transfer of the ...
5
Thrombin induction of plasminogen activator inhibitor in cultured human endothelial cells
... in PA-I ...of PA-I activity required active alpha-thrombin and was not obtained with gamma-thrombin nor with thrombin catalytically inactivated with ...of PA-I, PA activity was not measurable ...
6
Feasibility and efficacy of thrombolysis in acute ischemic stroke: A study from National Institute of Neurological and Allied Sciences, Kathmandu, Nepal.
... Our initial encouraging results with rt‑PA prompted us to use a more safer agent TNK because of mainly two reasons: (1) rt‑PA was not imported by the pharmaceuticals because it was not used in the country ...
6
A study on factors influencing the Outcome of Thrombolysis in Acute Myocardial Infarction
... plasminogen activator inhibitor from endothelium enhancement of plasminogen activation by f-fibrin and plasmin inhibiton by alpha 2 antiplasmin ...for plasminogen and plasminogen ...
83
Inhibition of angiogenesis by platelets in systemic sclerosis patients
... move residual leukocytes and finally resuspended in the same Ca 2+ -free buffer. Leukocyte contamination was evaluated by fluorescence microscopy using propidium iodide staining. Leukocyte counts were always less than ...
9
High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study
... of plasminogen activator inhibitor-1 (PAI-1) were strongly related to the development of diabetes independ- ent from insulin resistance and obesity ...tissue plasminogen activator (tPA) or the ...
7